Clinical Trial Update: A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating MK-1045 in people with systemic lupus erythematosus or rheumatoid arthritis. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis
• Systemic Lupus Erythematosus

Drugs mentioned

• MK-1045

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Systemic Lupus Erythematosus, Rheumatoid Arthritis | Phase 1 | Status: RECRUITING